Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001209191-23-058954

VP, Clinical Trial Operations sold 32,535 shares at an average $13.16 ($428,180)

From the SEC's structured data for this filing

Trades in this filing

Yu Yong · VP, Clinical Trial Operations

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-15 Sale : show line 1 in the form −26,732 $12.94 $345,915 5,803 D
2023-12-15 Sale : show line 2 in the form −5,803 $14.18 $82,265 0 D
Open-market sales · 32,535 sh · avg $13.16 · $428,180
Loading xslF345X05/doc4.xml…